SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027405
Filing Date
2016-11-03
Accepted
2016-11-03 16:40:51
Documents
82
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-10q_20160930.htm 10-Q 1950377
2 EX-31.1 ctmx-ex311_9.htm EX-31.1 19694
3 EX-31.2 ctmx-ex312_8.htm EX-31.2 20010
4 EX-32.1 ctmx-ex321_7.htm EX-32.1 10083
5 EX-32.2 ctmx-ex322_10.htm EX-32.2 10245
  Complete submission text file 0001564590-16-027405.txt   7468901

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctmx-20160930.xml EX-101.INS 1557224
7 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20160930.xsd EX-101.SCH 63378
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20160930_cal.xml EX-101.CAL 52295
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20160930_def.xml EX-101.DEF 220895
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20160930_lab.xml EX-101.LAB 437443
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20160930_pre.xml EX-101.PRE 365958
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 161972253
SIC: 2834 Pharmaceutical Preparations